Current status of IVF immunotherapy
IVF immunotherapy refers to that babies born through artificial assisted reproductive technology receive specific immunotherapy in their early life stage to enhance the function and resistance of their immune system. This treatment has been popularized and applied in many medical institutions, and has achieved certain results. The current situation of IVF immunotherapy will be described in detail from four aspects.
Objectives and methods of immunotherapy
The goal of IVF immunotherapy is to enhance the immune system function of infants, so that they can better resist bacteria, viruses and other diseases. To achieve this goal, doctors usually use two main immunotherapy methods: providing immune factors and immune cells. Among them, the way to provide immune factors is to inject specific immune factors into infants to enhance their immune function. The way to provide immune cells is to extract immune cells from healthy donors and inject them into infants after treatment.
In recent years, with the continuous progress of biotechnology, IVF immunotherapy methods are also constantly innovating and improving. Some medical institutions have begun to use gene editing technology to modify the immune genes of test tube babies, so as to realize the immunotherapy. The advantage of this method is that it can be accurately adjusted and treated according to the specific situation and needs of infants.
Medical institutions for immunotherapy
At present, there are many well-known medical institutions around the world that provide IVF immunotherapy services. For example, Boston Children's Hospital affiliated to Harvard Medical School in the United States is a leading world-class medical institution. Its immunotherapy center has a team of professional pediatricians and immunologists, committed to providing the most advanced and high-quality immunotherapy for test tube babies.
In addition, some medical institutions in China have made remarkable achievements in IVF immunotherapy. For example, Peking University First Hospital is one of the medical institutions that started IVF immunotherapy earlier in China, and its immunotherapy team has rich experience in diagnosis, treatment and scientific research.
Effects and side effects of immunotherapy
Current research shows that IVF immunotherapy can, to a certain extent, enhance the immune function of infants and improve their resistance. Some clinical observations also found that IVF infants receiving immunotherapy performed better in resisting bacterial and viral infections, and the incidence and severity of diseases were relatively low.
However, immunotherapy also has some side effects and risks. Some studies have found that in the course of immunotherapy, infants may experience discomfort, skin reactions, fever and other adverse reactions. In addition, long-term immunotherapy may have a certain impact on the infant's immune system and overall health, so doctors need to closely monitor and adjust the treatment plan.
Summary
IVF immunotherapy is a therapeutic method to enhance the immune function of infants by providing immune factors or immune cells. At present, medical institutions such as Boston Children's Hospital in the United States and Peking University First Hospital in China have rich experience and advanced equipment in IVF immunotherapy. Although immunotherapy can improve the resistance of infants, there are also some side effects and risks. Therefore, medical institutions should be carefully selected and doctors' suggestions should be followed when carrying out immunotherapy.
